Clinical Research Institute of Michigan – Shores Rheumatology
Main: 586-598-3329
Study Coordinator: Amelia Laurence 586-598-3329 X 201
Study Coordinator: Latrece Keaton 586-598-3329 X 202
- Indication: Systemic Lupus Erythematosus
- Enrollment Status: Open
- Protocol: BEACON
- Drug: Benlysta
- Sponsor: GSK
- Description: Belimumab for Early Action and Rheumatology Outcomes in Real-World Systemic Lupus Erythematosus Care (BEACON-SLE)